The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 60-66

  Kim, Jae Hak ^a   OH, Sun Hee ^a   Kim, Eo Jin ^b   Park, Soo Jung ^a   Hong, Sung Pil ^a   Cheon, Jae Hee ^a   Kim, Tae Il ^a   Kim, Won Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Myeloid cells; Myofibroblasts; S100A8; S100A9; Tumor microenvironment

Indexed keywords

ARGINASE 1; CALGRANULIN A; CALGRANULIN B; CD163 ANTIGEN; CD33 ANTIGEN; CD68 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; VASCULOTROPIN;

ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; COCULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

CALGRANULIN A; CALGRANULIN B; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MYELOID CELLS; MYOFIBROBLASTS; NEOPLASM INVASIVENESS; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84862662325     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.081     Document Type: Article

References (29)

1. Foell D., Frosch M., Sorg C., Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta 2004, 344:37-51.
2. Yong H.Y., Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 2007, 30:75-81.
3. Shen J., Person M.D., Zhu J., Abbruzzese J.L., Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004, 64:9018-9026.
4. Hiratsuka S., Watanabe A., Aburatani H., Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 2006, 8:1369-1375.
5. Cross S.S., Hamdy F.C., Deloulme J.C., Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269.
6. Ghavami S., Kerkhoff C., Los M., Hashemi M., Sorg C., Karami-Tehrani F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukocyte Biol. 2004, 76:169-175.
7. Ghavami S., Rashedi I., Dattilo B.M., Eshraghi M., Chazin W.J., Hashemi M., Wesselborg S., Kerkhoff C., Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukocyte Biol. 2008, 83:1484-1492.
8. Ang C.W., Nedjadi T., Sheikh A.A., Tweedle E.M., Tonack S., Honap S., Jenkins R.E., Park B.K., Schwarte-Waldhoff I., Khattak I., Azadeh B., Dodson A., Kalirai H., Neoptolemos J.P., Rooney P.S., Costello E. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis 2010, 31:1541-1551.
9. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 2007, 117:1155-1166.
10. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
11. Ichikawa M., Williams R., Wang L., Vogl T., Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 2011, 9:133-148.
12. De Wever O., Demetter P., Mareel M., Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 2008, 123:2229-2238.
13. De Wever O., Mareel M. Role of myofibroblasts at the invasion front. Biol. Chem. 2002, 383:55-67.
14. Adegboyega P.A., Mifflin R.C., DiMari J.F., Saada J.I., Powell D.W. Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch. Pathol. Lab. Med. 2002, 126:829-836.
15. Andoh A., Fujino S., Okuno T., Fujiyama Y., Bamba T. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J. Gastroenterol. 2002, 37(Suppl 14):33-37.
16. Peddareddigari V.G., Wang D., Dubois R.N. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 2010, 3:149-166.
17. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
18. Ostman A., Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr. Opin. Genet. Dev. 2009, 19:67-73.
19. Frosch M., Strey A., Vogl T., Wulffraat N.M., Kuis W., Sunderkotter C., Harms E., Sorg C., Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43:628-637.
20. Cheng P., Corzo C.A., Luetteke N., Yu B., Nagaraj S., Bui M.M., Ortiz M., Nacken W., Sorg C., Vogl T., Roth J., Gabrilovich D.I. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 2008, 205:2235-2249.
21. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182:4499-4506.
22. Erreni M., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron. 2011, 4:141-154.
23. Grivennikov S., Karin M. Autocrine IL-6 signaling: a key event in tumorigenesis?. Cancer Cell 2008, 13:7-9.
24. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049.
25. Mueller L., von Seggern L., Schumacher J., Goumas F., Wilms C., Braun F., Broering D.C. TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts. Biochem. Biophys. Res. Commun. 2010, 397:586-591.
26. Zhou J., Wu J., Chen X., Fortenbery N., Eksioglu E., Kodumudi K.N., Pk E.B., Dong J., Djeu J.Y., Wei S. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int. Immunopharmacol. 2011, 11:890-898.
27. Nukui T., Ehama R., Sakaguchi M., Sonegawa H., Katagiri C., Hibino T., Huh N.H. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J. Cell Biochem. 2008, 104:453-464.
28. Etoh T., Shibuta K., Barnard G.F., Kitano S., Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin. Cancer Res. 2000, 6:3545-3551.
29. Sickert D., Aust D.E., Langer S., Haupt I., Baretton G.B., Dieter P. Characterization of macrophage subpopulations in colon cancer using tissue microarrays. Histopathology 2005, 46:515-521.